Several trades totally almost 7,000 shares were eager to buy astx around the 4.70 range. We may see $5 soon. I believe something at AACR is going to be welcome news when the full details are discussed. If sgi-110 is a great agent as a priming drug, then just maybe most doctors, may turn to it first, before chemo to jump start the immune system. Look we have seen lung, brain and ovarian cancer showing improvements, when using these agents first. The key is how the side effects are much lower than vidaza/dacogen, the drug stays in the system 4 times longer. They also have a biomarker to gauge if the drug's working.